{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:41:12Z","timestamp":1781664072088,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s40123-019-0201-y","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T16:02:37Z","timestamp":1563292957000},"page":"353-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Should Patients with Hidradenitis Suppurativa Undergo LASIK?"],"prefix":"10.1007","volume":"8","author":[{"given":"David B.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-6250","authenticated-orcid":false,"given":"Majid","family":"Moshirfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline B.","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmyne C.","family":"Ronquillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip C.","family":"Hoopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"20","key":"201_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2017.16691","volume":"318","author":"DML Saunte","year":"2017","unstructured":"Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017;318(20):2019\u201332. https:\/\/doi.org\/10.1001\/jama.2017.16691.","journal-title":"JAMA"},{"issue":"5","key":"201_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","volume":"14","author":"J von der Werth","year":"2000","unstructured":"von der Werth J, Williams H. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14(5):389\u201392. https:\/\/doi.org\/10.1046\/j.1468-3083.2000.00087.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"201_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12788\/j.sder.2017.017","volume":"36","author":"L Hoffman","year":"2017","unstructured":"Hoffman L, Ghias M, Lowes M. Pathophysiology of hidradenitis suppurativa. Semin Cutan Med Surg. 2017;36(2):47\u201354. https:\/\/doi.org\/10.12788\/j.sder.2017.017.","journal-title":"Semin Cutan Med Surg"},{"issue":"3","key":"201_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5152\/eurjrheum.2018.17163","volume":"5","author":"D Sayg\u0131n","year":"2018","unstructured":"Sayg\u0131n D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol. 2018;5(3):165\u20138. https:\/\/doi.org\/10.5152\/eurjrheum.2018.17163.","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"201_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","volume":"19","author":"M von Laffert","year":"2009","unstructured":"von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2009;19(6):533\u20137. https:\/\/doi.org\/10.1111\/j.1600-0625.2009.00915.x.","journal-title":"Exp Dermatol"},{"issue":"2","key":"201_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","volume":"166","author":"HH van der Zee","year":"2012","unstructured":"van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP. Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. Br J Dermatol. 2012;166(2):298\u2013305. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10698.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"201_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10643.x","volume":"166","author":"HH van der Zee","year":"2012","unstructured":"van der Zee HH, de Ruiter L, Boer J, et al. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol. 2012;166(1):98\u2013106. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10643.x.","journal-title":"Br J Dermatol"},{"issue":"10","key":"201_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/ijd.12550","volume":"53","author":"G Kelly","year":"2014","unstructured":"Kelly G, Sweeney CM, Tobin A-M, Kirby B. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol. 2014;53(10):1186\u201396. https:\/\/doi.org\/10.1111\/ijd.12550.","journal-title":"Int J Dermatol"},{"issue":"10","key":"201_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","volume":"21","author":"HH van der Zee","year":"2012","unstructured":"van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012;21(10):735\u20139. https:\/\/doi.org\/10.1111\/j.1600-0625.2012.01552.x.","journal-title":"Exp Dermatol"},{"issue":"6","key":"201_CR10","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH van der Zee","year":"2011","unstructured":"van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2. Br J Dermatol. 2011;164(6):1292\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10254.x.","journal-title":"Br J Dermatol"},{"key":"201_CR11","doi-asserted-by":"crossref","unstructured":"Fitzsimmons JS, Guilbert PR, Fitzsimmons EM. Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol. 1985;113(1):1\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4015966. Accessed 15 May 2019.","DOI":"10.1111\/j.1365-2133.1985.tb02037.x"},{"issue":"8","key":"201_CR12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.jid.2016.04.021","volume":"136","author":"EJ Giamarellos-Bourboulis","year":"2016","unstructured":"Giamarellos-Bourboulis EJ, Platzer M, Karagiannidis I, et al. High copy numbers of \u03b2-defensin cluster on 8p23.1, confer genetic susceptibility, and modulate the physical course of hidradenitis suppurativa\/acne inversa. J Invest Dermatol. 2016;136(8):1592\u20138. https:\/\/doi.org\/10.1016\/j.jid.2016.04.021.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"201_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","volume":"34","author":"IM Miller","year":"2016","unstructured":"Miller IM, McAndrew RJ, Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):7\u201316. https:\/\/doi.org\/10.1016\/j.det.2015.08.002.","journal-title":"Dermatol Clin"},{"issue":"3","key":"201_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bjd.13002","volume":"171","author":"HH van der Zee","year":"2014","unstructured":"van der Zee HH, de Winter K, van der Woude CJ, Prens EP. The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease. Br J Dermatol. 2014;171(3):673\u20135. https:\/\/doi.org\/10.1111\/bjd.13002.","journal-title":"Br J Dermatol"},{"key":"201_CR15","doi-asserted-by":"crossref","unstructured":"Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn\u2019s disease. Int J Colorectal Dis. 1993;8(3):117\u2013119. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8245664. Accessed 15 May 2019.","DOI":"10.1007\/BF00341181"},{"issue":"8","key":"201_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","volume":"18","author":"V Bruzzese","year":"2012","unstructured":"Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis. J Clin Rheumatol. 2012;18(8):413\u20135. https:\/\/doi.org\/10.1097\/RHU.0b013e318278b84c.","journal-title":"J Clin Rheumatol"},{"key":"201_CR17","unstructured":"Lapins J, Ye W, Nyr\u00e9n O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001;137(6):730\u2013734. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11405761. Accessed 15 May 2019."},{"issue":"10","key":"201_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/ICO.0b013e3181d4fd5c","volume":"29","author":"AG Alzaga Fernandez","year":"2010","unstructured":"Alzaga Fernandez AG, Demirci H, Darnley-Fisch DA, Steen DW. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review. Cornea. 2010;29(10):1189\u201391. https:\/\/doi.org\/10.1097\/ICO.0b013e3181d4fd5c.","journal-title":"Cornea"},{"issue":"5","key":"201_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/09273948.2011.584653","volume":"19","author":"SW Meskin","year":"2011","unstructured":"Meskin SW, Carlson EM. Mooren\u2019s-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review. Ocul Immunol Inflamm. 2011;19(5):340\u20132. https:\/\/doi.org\/10.3109\/09273948.2011.584653.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"201_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0161-6420(94)31291-7","volume":"101","author":"SE Wilson","year":"1994","unstructured":"Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 1994;101(4):736\u201345. https:\/\/doi.org\/10.1016\/S0161-6420(94)31291-7.","journal-title":"Ophthalmology"},{"issue":"5","key":"201_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archopht.1967.00980020637012","volume":"77","author":"DD Sachs","year":"1967","unstructured":"Sachs DD, Gordon AT. Hidradenitis suppurativa of glands of Moll. Arch Ophthalmol. 1967;77(5):635\u20136. https:\/\/doi.org\/10.1001\/archopht.1967.00980020637012.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"201_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/J.1523-1747.2003.12328.X","volume":"121","author":"BM Stoeckelhuber","year":"2003","unstructured":"Stoeckelhuber BM, Welsch U, Stoeckelhuber M. Human glands of Moll: histochemical and ultrastructural characterization of the glands of Moll in the human eyelid. J Invest Dermatol. 2003;121(1):28\u201336. https:\/\/doi.org\/10.1046\/J.1523-1747.2003.12328.X.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"201_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3109\/01676830.2014.894542","volume":"33","author":"AS Hassan","year":"2014","unstructured":"Hassan AS, Saldana M, Wearne M. Hidradenitis suppurativa of the periorbital skin with lacrimal sac and ethmoidal involvement. Orbit. 2014;33(5):382\u20134. https:\/\/doi.org\/10.3109\/01676830.2014.894542.","journal-title":"Orbit"},{"issue":"12","key":"201_CR24","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jcrs.2016.09.018","volume":"42","author":"JM Schallhorn","year":"2016","unstructured":"Schallhorn JM, Schallhorn SC, Hettinger KA, et al. Outcomes and complications of excimer laser surgery in patients with collagen vascular and other immune-mediated inflammatory diseases. J Cataract Refract Surg. 2016;42(12):1742\u201352. https:\/\/doi.org\/10.1016\/j.jcrs.2016.09.018.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"201_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/archderm.1974.01630030062019","volume":"109","author":"KE Greer","year":"1974","unstructured":"Greer KE. Facial involvement with hidradenitis suppurativa. Arch Dermatol. 1974;109(3):408. https:\/\/doi.org\/10.1001\/archderm.1974.01630030062019.","journal-title":"Arch Dermatol"},{"issue":"2","key":"201_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000315508","volume":"221","author":"F Poli","year":"2010","unstructured":"Poli F, Wolkenstein P, Revuz J. Back and face involvement in hidradenitis suppurativa. Dermatology. 2010;221(2):137\u201341. https:\/\/doi.org\/10.1159\/000315508.","journal-title":"Dermatology"},{"issue":"11","key":"201_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archopht.1994.01090230074023","volume":"112","author":"DS Bardenstein","year":"1994","unstructured":"Bardenstein DS, Haluschak J, Gerson S, Zaim MT. Neutrophilic eccrine hidradenitis simulating orbital cellulitis. Arch Ophthalmol. 1994;112(11):1460. https:\/\/doi.org\/10.1001\/archopht.1994.01090230074023.","journal-title":"Arch Ophthalmol"},{"key":"201_CR28","unstructured":"Mastrota KM. Hidradenitis suppurativa masquerades as blepharitis. 2018. https:\/\/www.optometrytimes.com\/blepharitis\/hidradenitis-suppurativa-masquerades-blepharitis. Accessed 16 May 2019."},{"issue":"2","key":"201_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GBE Jemec","year":"2012","unstructured":"Jemec GBE. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158\u201364. https:\/\/doi.org\/10.1056\/NEJMcp1014163.","journal-title":"N Engl J Med"},{"issue":"4","key":"201_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/ICU.0000000000000055","volume":"25","author":"KS Bower","year":"2014","unstructured":"Bower KS, Woreta F. Update on contraindications for laser-assisted in situ keratomileusis and photorefractive keratectomy. Curr Opin Ophthalmol. 2014;25(4):251\u20137. https:\/\/doi.org\/10.1097\/ICU.0000000000000055.","journal-title":"Curr Opin Ophthalmol"},{"key":"201_CR31","unstructured":"Proch\u00e1zkov\u00e1 S, Netukov\u00e1 M, Klecka D, Nov\u00e1k P. Lasik after corneal ulcer. Cesk Slov Oftalmol. 2011;67(3):86\u201389. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22132646. Accessed 14 May 2019."},{"issue":"8","key":"201_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3928\/1081597X-20120722-01","volume":"28","author":"JB Randleman","year":"2012","unstructured":"Randleman JB, Shah RD. LASIK interface complications: etiology, management, and outcomes. J Refract Surg. 2012;28(8):575\u201386. https:\/\/doi.org\/10.3928\/1081597X-20120722-01.","journal-title":"J Refract Surg"},{"issue":"8","key":"201_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/J.JCRS.2006.02.059","volume":"32","author":"RJ Smith","year":"2006","unstructured":"Smith RJ, Maloney RK. Laser in situ keratomileusis in patients with autoimmune diseases. J Cataract Refract Surg. 2006;32(8):1292\u20135. https:\/\/doi.org\/10.1016\/J.JCRS.2006.02.059.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"201_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/0974-9233.124082","volume":"21","author":"M AlKharashi","year":"2014","unstructured":"AlKharashi M, Bower KS, Stark WJ, Daoud YJ. Refractive surgery in systemic and autoimmune disease. Middle East Afr J Ophthalmol. 2014;21(1):18\u201324. https:\/\/doi.org\/10.4103\/0974-9233.124082.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"1","key":"201_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000336567","volume":"3","author":"M Aman-Ullah","year":"2012","unstructured":"Aman-Ullah M, Gimbel HV, Purba MK, van Westenbrugge JA. Necrotizing keratitis after laser refractive surgery in patients with inactive inflammatory bowel disease. Case Rep Ophthalmol. 2012;3(1):54\u201360. https:\/\/doi.org\/10.1159\/000336567.","journal-title":"Case Rep Ophthalmol"},{"issue":"2\u20133","key":"201_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000477207","volume":"233","author":"CM Huang","year":"2017","unstructured":"Huang CM, Kirchhof MG. A new perspective on isotretinoin treatment of hidradenitis suppurativa: a retrospective chart review of patient outcomes. Dermatology. 2017;233(2\u20133):120\u20135. https:\/\/doi.org\/10.1159\/000477207.","journal-title":"Dermatology"},{"issue":"1","key":"201_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/ICO.0b013e318183a396","volume":"28","author":"A Karalezli","year":"2009","unstructured":"Karalezli A, Borazan M, Altinors DD, Dursun R, Kiyici H, Akova YA. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea. 2009;28(1):46\u201350. https:\/\/doi.org\/10.1097\/ICO.0b013e318183a396.","journal-title":"Cornea"},{"key":"201_CR38","doi-asserted-by":"publisher","first-page":"d3353","DOI":"10.1136\/bmj.d3353","volume":"342","author":"M Malik","year":"2011","unstructured":"Malik M, Simpson RC, Varma S. Isotretinoin as contraindication. BMJ. 2011;342:d3353. https:\/\/doi.org\/10.1136\/bmj.d3353.","journal-title":"BMJ."},{"key":"201_CR39","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Irke\u00e7 MT, Atakan N, Orhan M, Geyik PO. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol. 12(3):173\u2013176. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12113560. Accessed 05 July 2019.","DOI":"10.1177\/112067210201200316"},{"issue":"4","key":"201_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/OPX.0000000000001196","volume":"95","author":"S Li","year":"2018","unstructured":"Li S, Kim YH, Li W, Lin MC, Radke CJ. Human lacrimal production rates from modified Schirmer-tear test. Optom Vis Sci. 2018;95(4):343\u20138. https:\/\/doi.org\/10.1097\/OPX.0000000000001196.","journal-title":"Optom Vis Sci"},{"key":"201_CR41","doi-asserted-by":"crossref","unstructured":"Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland morphology and tear osmolarity: changes with accutane therapy. Cornea. 1991;10(4):286\u2013290. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1832371. Accessed 16 May 2019.","DOI":"10.1097\/00003226-199107000-00002"},{"issue":"1","key":"201_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/bjophthalmol-2016-310097","volume":"102","author":"SL Maskin","year":"2018","unstructured":"Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2018;102(1):59\u201368. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310097.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"201_CR43","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/ICO.0000000000000273","volume":"33","author":"D Finis","year":"2014","unstructured":"Finis D, K\u00f6nig C, Hayajneh J, Borrelli M, Schrader S, Geerling G. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea. 2014;33(12):1265\u201370. https:\/\/doi.org\/10.1097\/ICO.0000000000000273.","journal-title":"Cornea"},{"issue":"1","key":"201_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","volume":"80","author":"NM Golbari","year":"2019","unstructured":"Golbari NM, Porter ML, Kimball AB. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2019;80(1):114\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.063.","journal-title":"J Am Acad Dermatol"},{"key":"201_CR45","doi-asserted-by":"crossref","unstructured":"Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci. 2002;966:211\u2013222. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12114274. Accessed 21 May 2019.","DOI":"10.1111\/j.1749-6632.2002.tb04217.x"},{"issue":"4","key":"201_CR46","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/bjd.14338","volume":"174","author":"JL Blok","year":"2016","unstructured":"Blok JL, Li K, Brodmerkel C, Horv\u00e1tovich P, Jonkman MF, Horv\u00e1th B. Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. Br J Dermatol. 2016;174(4):839\u201346. https:\/\/doi.org\/10.1111\/bjd.14338.","journal-title":"Br J Dermatol"},{"issue":"5","key":"201_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375(5):422\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1504370.","journal-title":"N Engl J Med"},{"key":"201_CR48","unstructured":"Safety Information for HUMIRA (adalimumab) | rheumatology. https:\/\/www.humirapro.com\/rheumatology\/safety-data. Accessed 21 May 2019."},{"issue":"1","key":"201_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12348-018-0153-8","volume":"8","author":"W Bernauer","year":"2018","unstructured":"Bernauer W, Schuler S, Borradori L. Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid. J Ophthalmic Inflamm Infect. 2018;8(1):12. https:\/\/doi.org\/10.1186\/s12348-018-0153-8.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"9","key":"201_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/infdis\/jit350","volume":"208","author":"M van Velzen","year":"2013","unstructured":"van Velzen M, van de Vijver DAMC, van Loenen FB, Osterhaus ADME, Remeijer L, Verjans GMGM. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis. 2013;208(9):1359\u201365. https:\/\/doi.org\/10.1093\/infdis\/jit350.","journal-title":"J Infect Dis"},{"issue":"4","key":"201_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ofid\/ofw205","volume":"3","author":"F Marra","year":"2016","unstructured":"Marra F, Lo E, Kalashnikov V, Richardson K. Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and\/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis. Open forum Infect Dis. 2016;3(4):205. https:\/\/doi.org\/10.1093\/ofid\/ofw205.","journal-title":"Open forum Infect Dis"},{"key":"201_CR52","unstructured":"Tsuyuguchi K, Matsumoto T. [Biologics and mycobacterial diseases]. Kekkaku. 2013;88(3):337\u2013353. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23672175. Accessed 17 May 2019."},{"issue":"51","key":"201_CR53","doi-asserted-by":"publisher","first-page":"e9356","DOI":"10.1097\/MD.0000000000009356","volume":"96","author":"J Ko","year":"2017","unstructured":"Ko J, Kim SK, Yong DE, Kim T, Kim EK. Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis. Medicine (Baltimore). 2017;96(51):e9356. https:\/\/doi.org\/10.1097\/MD.0000000000009356.","journal-title":"Medicine (Baltimore)"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-019-0201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-019-0201-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-019-0201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T16:03:28Z","timestamp":1713283408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-019-0201-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1007\/s40123-019-0201-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}